PhenoSense GT™ is a resistance test that combines three proven tests,
PhenoSense™ HIV, GeneSeq™ HIV, and Replication Capacity (RC), to make up one complete picture of drug resistance. The combination test is performed from the same blood sample and is reported on one report form. The PhenoSense GT report places phenotypic, genotypic, and RC (also referred to as viral fitness) results side by side so that healthcare providers can select the best possible therapy for a person living with HIV.
Basically, PhenoSense GT looks at an individual's HIV from all possible ways so that the most effective treatment can be selected. PhenoSense GT uses advanced technology and offers consistency because both phenotypic and genotypic results come from the same blood sample. Click here to learn more about the use of phenotyping and genotyping together.
PhenoSense GT requires a blood sample and 14 days for results to be returned. The report form includes both phenotypic and genotypic drug resistance information for all of the approved NRTIs, NNRTIs, and PIs. Below is a sample PhenoSense GT report form to provide a better idea of how the drug resistance and RC information is reported.
Click on the image below to enlarge the form.
Get the latest information on
individualized medicine
